
This zzso randomized, zzso study compared the efficacy and safety of zzso oral zzso 2 zzso zzso zzso zzso and zzso zzso zzso zzso as prophylaxis for zzso and zzso in patients receiving upper abdominal zzso zzso Patients were scheduled to receive zzso zzso of zzso zzso zzso zzso zzso or zzso was administered 1 zzso before zzso on each scheduled treatment zzso Treatment comparisons were made at 24 zzso and at 10 and 20 zzso Patients treated with zzso experienced greater zzso control than those treated with zzso as evidenced by median times to first zzso (35 zzso 9 days, p zzso zzso and first zzso (11 zzso 1 day, p zzso zzso zzso zzso analysis showed that zzso more zzso than zzso patients were zzso free zzso zzso zzso p zzso zzso and zzso free zzso zzso zzso p zzso zzso Furthermore, zzso more zzso than zzso patients were zzso free and zzso more were zzso free on at least zzso of study treatment zzso The most commonly reported adverse experiences in zzso patients were zzso zzso and zzso These findings demonstrate that a zzso zzso dose of oral zzso is well tolerated and significantly more effective than zzso in preventing zzso and zzso induced by zzso zzso to the upper zzso 

